Weiss Multi-Strategy Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,000
Closed -$1.62M 670
2022
Q3
$1.62M Buy
+5,000
New +$1.58M 0.04% 437
2019
Q4
Sell
-100,000
Closed -$11.2M 671
2019
Q3
$11.2M Buy
+100,000
New +$11.1M 0.23% 127
2019
Q1
Sell
-5,000
Closed -$579K 569
2018
Q4
$579K Buy
+5,000
New +$559K 0.02% 339

Other funds holding LLY

Weiss Multi-Strategy Advisers's LLY Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 18,126 shares — an estimated $10.6M sold.

Weiss Multi-Strategy Advisers first reported a position in LLY in Q3 2013 and held it in 22 quarters. The position peaked at $17.5M in Q1 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 18,126 Eli Lilly shares in Q1 2024, an estimated $10.6M.
  • Weiss Multi-Strategy Advisers first reported a position in Eli Lilly in Q3 2013 and held it in 22 quarters.
  • Weiss Multi-Strategy Advisers's Eli Lilly position peaked at $17.5M in Q1 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.